Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
| MER Indicator |
MER description |
Target Fiscal Year |
Target |
| HTS_TST |
By Key Population: FSW, Negative |
2018 |
68 |
| HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2018 |
50,936 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 20-24, Female, Negative |
2018 |
11 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 20-24, Male, Negative |
2018 |
9 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 25-49, Female, Negative |
2018 |
162 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 25-49, Male, Negative |
2018 |
182 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative |
2018 |
15 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative |
2018 |
21 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative |
2018 |
58 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative |
2018 |
84 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative |
2018 |
567 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative |
2018 |
482 |
| HTS_TST |
Service Delivery Point (Facility) Malnutrition: Negative |
2018 |
1,290 |
| HTS_TST |
Service Delivery Point (Facility) Pediatric : <5 Negative |
2018 |
1,838 |
| HTS_TST |
Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative |
2018 |
59 |
| HTS_TST |
Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative |
2018 |
50 |
| HTS_TST |
Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative |
2018 |
740 |
| HTS_TST |
Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative |
2018 |
707 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative |
2018 |
2,207 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative |
2018 |
380 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative |
2018 |
351 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative |
2018 |
6,104 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative |
2018 |
3,785 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative |
2018 |
337 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative |
2018 |
459 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative |
2018 |
5,779 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative |
2018 |
5,530 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative |
2018 |
57 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative |
2018 |
74 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative |
2018 |
535 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative |
2018 |
436 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative |
2018 |
453 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative |
2018 |
515 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative |
2018 |
3,830 |
| HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative |
2018 |
2,950 |
| HTS_TST |
Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Female, Negative |
2018 |
18 |
| HTS_TST |
Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Male, Negative |
2018 |
12 |
| HTS_TST |
Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative |
2018 |
40 |
| HTS_TST |
Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative |
2018 |
41 |
| HTS_TST |
Sum of Test Result disaggregates |
2018 |
2,557 |
| HTS_TST_POS |
By Key Population: FSW, Positive |
2018 |
2 |
| HTS_TST_POS |
By Test Result: Positive |
2018 |
2,557 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 20-24, Female, Positive |
2018 |
1 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 20-24, Male, Positive |
2018 |
1 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 25-49, Female, Positive |
2018 |
7 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 25-49, Male, Positive |
2018 |
12 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive |
2018 |
1 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive |
2018 |
1 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive |
2018 |
3 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive |
2018 |
2 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive |
2018 |
13 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive |
2018 |
9 |
| HTS_TST_POS |
Service Delivery Point (Facility) Malnutrition: Positive |
2018 |
98 |
| HTS_TST_POS |
Service Delivery Point (Facility) Pediatric : <5 Positive |
2018 |
148 |
| HTS_TST_POS |
Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive |
2018 |
4 |
| HTS_TST_POS |
Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive |
2018 |
3 |
| HTS_TST_POS |
Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive |
2018 |
81 |
| HTS_TST_POS |
Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive |
2018 |
58 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive |
2018 |
153 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive |
2018 |
29 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive |
2018 |
30 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive |
2018 |
408 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive |
2018 |
201 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive |
2018 |
9 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive |
2018 |
16 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive |
2018 |
451 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive |
2018 |
419 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive |
2018 |
14 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive |
2018 |
11 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive |
2018 |
38 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive |
2018 |
30 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive |
2018 |
21 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive |
2018 |
26 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive |
2018 |
236 |
| HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive |
2018 |
127 |
| HTS_TST_POS |
Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive |
2018 |
1 |
| HTS_TST_POS |
Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive |
2018 |
1 |
| KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
70 |
| KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2018 |
70 |
| PMTCT_ART |
New on ART |
2018 |
472 |
| PMTCT_ART |
Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy |
2018 |
472 |
| PMTCT_ART |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2018 |
12,270 |
| PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2018 |
438 |
| PMTCT_EID |
Number of infants with a negative virological test result between 2 and 12 months of birth |
2018 |
403 |
| PMTCT_EID |
Number of infants with a positive virological test result between 2 and 12 months of birth |
2018 |
35 |
| PMTCT_STAT |
By Age (Numerator): 25-49 |
2018 |
12,270 |
| PMTCT_STAT |
By Number of new negative: 25-49 |
2018 |
11,716 |
| PMTCT_STAT |
By Number of new positives: 25-49 |
2018 |
552 |
| PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2018 |
12,270 |
| PMTCT_STAT_den |
By Age (Denominator): 25-49 |
2018 |
12,622 |
| TB_ART |
Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) |
2018 |
7 |
| TB_ART |
Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) |
2018 |
129 |
| TB_ART |
Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) |
2018 |
6 |
| TB_ART |
Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) |
2018 |
79 |
| TB_ART |
The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period |
2018 |
221 |
| TB_ART |
The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period |
2018 |
221 |
| TB_ART_den |
Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) |
2018 |
7 |
| TB_ART_den |
Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) |
2018 |
129 |
| TB_ART_den |
Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) |
2018 |
6 |
| TB_ART_den |
Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) |
2018 |
79 |
| TB_STAT |
Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) |
2018 |
23 |
| TB_STAT |
Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) |
2018 |
407 |
| TB_STAT |
Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) |
2018 |
36 |
| TB_STAT |
Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) |
2018 |
216 |
| TB_STAT |
Number of registered new and relapsed TB cases with documented HIV status, during the reporting period |
2018 |
682 |
| TB_STAT |
Total number of registered new and relapsed TB cases, during the reporting period |
2018 |
719 |
| TB_STAT_den |
Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) |
2018 |
24 |
| TB_STAT_den |
Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) |
2018 |
429 |
| TB_STAT_den |
Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) |
2018 |
38 |
| TB_STAT_den |
Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) |
2018 |
228 |
| TX_CURR |
Aggregated Age/Sex: <15 Female |
2018 |
86 |
| TX_CURR |
Aggregated Age/Sex: <15 Male |
2018 |
75 |
| TX_CURR |
Aggregated Age/Sex: 15+ Female |
2018 |
2,371 |
| TX_CURR |
Aggregated Age/Sex: 15+ Male |
2018 |
2,212 |
| TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2018 |
4,744 |
| TX_CURR |
Sum of Aggregated Age/Sex <15 |
2018 |
161 |
| TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2018 |
4,583 |
| TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2018 |
4,744 |
| TX_NEW |
Aggregated Grouping by Age/Sex: <15 Female |
2018 |
44 |
| TX_NEW |
Aggregated Grouping by Age/Sex: <15 Male |
2018 |
29 |
| TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2018 |
1,150 |
| TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2018 |
486 |
| TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2018 |
1,709 |
| TX_NEW |
Pregnancy status |
2018 |
163 |
| TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2018 |
1,709 |
| TX_RET |
Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2018 |
38 |
| TX_RET |
Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2018 |
45 |
| TX_RET |
Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2018 |
1,734 |
| TX_RET |
Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2018 |
1,551 |
| TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2018 |
3,373 |
| TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2018 |
4,299 |
| TX_RET_den |
Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2018 |
66 |
| TX_RET_den |
Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2018 |
55 |
| TX_RET_den |
Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2018 |
2,124 |
| TX_RET_den |
Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2018 |
2,054 |
